CCEP Stock Analysis: Coca-Cola European | NASDAQ
Beverages - Non-Alcoholic | NASDAQ, USA | Market Cap: 45.834m USD | 12M Return: 29.3% | GB00BDCPN049 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 175M
EPS Trend: -34.8%
Qual. Beats: 0
Rev. Trend: 93.4%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Coca-Cola Europacific Partners PLC (NASDAQ: CCEP) is a Uxbridge, UK-based bottler and distributor of non-alcoholic ready-to-drink beverages, operating as one of the largest independent Coca-Cola bottlers globally. The company manufactures, sells, and distributes a broad portfolio spanning soft drinks, water, energy drinks, isotonic drinks, tea, coffee, juices, and mixers, marketed under a wide range of owned and licensed brands including Coca-Cola Original Taste, Coca-Cola Zero Sugar, Diet Coke, Sprite, Fanta, Monster Energy, Dr Pepper, Schweppes, GLACEAU smartwater, Minute Maid, and Jack Daniels & Coca-Cola RTD, among many others. Founded in 1904 and originally listed in 1987, the company was renamed from Coca-Cola European Partners plc to Coca-Cola Europacific Partners PLC in May 2021, reflecting its geographic expansion beyond Europe.
The Coca-Cola bottling model is a franchise-style system in which The Coca-Cola Company owns the concentrate and brand trademarks, while anchor bottlers like CCEP handle local manufacturing, packaging, distribution, and customer relationships. This asset-heavy structure means bottlers typically generate high revenue volumes but operate on relatively thin margins, with profitability heavily influenced by input costs (notably PET, aluminum, sugar, and fuel), currency translation across multiple markets, and the ability to pass pricing through to retailers.
- Resin and aluminum cost inflation pressures gross margins
- Coca-Cola Amatil integration expands Asia-Pacific revenue base
- Sugar taxes across Europe pressure carbonated volume growth
| Net Income: 2.00b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.36 > 1.0 |
| NWC/Revenue: -4.87% < 20% (prev -7.71%; Δ 2.84% < -1%) |
| CFO/TA 0.09 > 3% & CFO 2.85b > Net Income 2.00b |
| Net Debt (10.9b) to EBITDA (3.84b): 2.84 < 3 |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (446.0m) vs 12m ago -3.04% < -2% |
| Gross Margin: 35.56% > 18% (prev 35.46%; Δ 0.10% > 0.5%) |
| Asset Turnover: 66.46% > 50% (prev 65.70%; Δ 0.76% > 0%) |
| Interest Coverage Ratio: 9.18 > 6 (EBIT TTM 2.94b / Interest Expense TTM 320.7m) |
| A: -0.03 (Total Current Assets 8.32b - Total Current Liabilities 9.36b) / Total Assets 32.5b |
| B: 0.28 (Retained Earnings 9.22b / Total Assets 32.5b) |
| C: 0.09 (EBIT TTM 2.94b / Avg Total Assets 32.1b) |
| D: 0.35 (Book Value of Equity 8.27b / Total Liabilities 23.7b) |
| Altman-Z'' = 1.70 = BB |
| DSRI: 1.03 (Receivables 3.54b/3.35b, Revenue 21.4b/20.9b) |
| GMI: 1.00 (GM 35.46% / 35.56%) |
| AQI: 1.00 (AQ_t 0.55 / AQ_t-1 0.55) |
| SGI: 1.02 (Revenue 21.4b / 20.9b) |
| TATA: -0.03 (NI 2.00b - CFO 2.85b) / TA 32.5b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of October 17, 2026, the stock is trading at USD 112.40 with a total of 1,984,242 shares traded. Over the past week, the price has changed by +7.82%, over one month by +9.41%, over three months by +5.99% and over the past year by +29.26%.
Current recommended Stop Loss: 109.50 (which is 2.6% or 1.4 ATR below the current price).
Coca-Cola European has received a consensus analysts rating of 4.08. Therefore, it is recommended to buy CCEP.
- StrongBuy: 7
- Buy: 1
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 109.2 | -2.9% |
Market Cap EUR = 40.9b (45.8b USD * 0.89180999994278 USD.EUR)
P/E Trailing = 20.0096
P/E Forward = 18.2482
P/S = 2.1467
P/B = 4.7406
P/EG = 2.6907
Revenue TTM = 21.4b EUR
EBIT TTM = 2.94b EUR
EBITDA TTM = 3.84b EUR
Long Term Debt = 9.69b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.66b EUR (from shortTermDebt, last quarter)
Debt = 12.9b EUR (from shortLongTermDebtTotal, last quarter) + Leases 699.0m
Net Debt = 10.9b EUR (calculated: Debt 12.9b - CCE 1.99b)
Enterprise Value = 51.8b EUR (40.9b + Debt 12.9b - CCE 1.99b)
Interest Coverage Ratio = 9.18 (Ebit TTM 2.94b / Interest Expense TTM 320.7m)
EV/FCF = 24.51x (Enterprise Value 51.8b / FCF TTM 2.11b)
FCF Yield = 4.08% (FCF TTM 2.11b / Enterprise Value 51.8b)
FCF Margin = 9.89% (FCF TTM 2.11b / Revenue TTM 21.4b)
Net Margin = 9.35% (Net Income TTM 2.00b / Revenue TTM 21.4b)
Gross Margin = 35.56% ((Revenue TTM 21.4b - Cost of Revenue TTM 13.8b) / Revenue TTM)
Gross Margin QoQ = 35.32% (prev 35.81%)
Tobins Q-Ratio = 1.59 (Enterprise Value 51.8b / Total Assets 32.5b)
Interest Expense / Debt = 2.49% (Interest Expense 320.7m / Debt 12.9b)
Taxrate = 23.23% (615.0m / 2.65b)
NOPAT = 2.26b (EBIT 2.94b * (1 - 23.23%))
Current Ratio = 0.89 (Total Current Assets 8.32b / Total Current Liabilities 9.36b)
Debt / Equity = 1.56 (Debt 12.9b / totalStockholderEquity, last quarter 8.27b)
Debt / EBITDA = 2.84 (Net Debt 10.9b / EBITDA 3.84b)
Debt / FCF = 5.16 (Net Debt 10.9b / FCF TTM 2.11b)
Total Stockholder Equity = 8.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.21% (Net Income 2.00b / Total Assets 32.5b)
RoE = 24.47% (Net Income TTM 2.00b / Total Stockholder Equity 8.16b)
RoCE = 16.50% (EBIT 2.94b / Capital Employed (Equity 8.16b + L.T.Debt 9.69b))
RoIC = 9.54% (NOPAT 2.26b / Invested Capital 23.7b)
WACC = 5.00% (E(40.9b)/V(53.8b) * Re(5.98%) + D(12.9b)/V(53.8b) * Rd(2.49%) * (1-Tc(0.23)))
Discount Rate = 5.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -57.28 | Cagr: -1.17%
[DCF] Terminal Value 75.00% ; FCFF base≈2.14b ; Y1≈2.09b ; Y5≈2.10b
[DCF] Fair Price = 49.96 (EV 32.9b - Net Debt 10.9b = Equity 22.0b / Shares 439.7m; r=8.35% [WACC [floored]]; 5y FCF grow -3.16% → 2.50% )
EPS Correlation: -34.77 | EPS CAGR: -15.18% | SUE: 0.0 | # QB: 0
Revenue Correlation: 93.40 | Revenue CAGR: 6.86% | SUE: 2.02 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=4.50 | Chg30d=+0.19% | Revisions=+0% | GrowthEPS=+5.1% | GrowthRev=+3.5%
EPS next Year (2027-12-31): EPS=4.92 | Chg30d=+0.21% | Revisions=+40% | GrowthEPS=+9.2% | GrowthRev=+3.9%
[Analyst] Revisions Ratio: +40% (up=2, down=0)